Vivace Therapeutics: Funding, Investors & Team (Sep 2026)
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.
Vivace Therapeutics has raised $65.0M across 2 funding rounds on record, the most recent a Series D of $35.0M announced in Mar 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Vivace Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Vivace Therapeutics Funding Rounds
Vivace Therapeutics raised $30.0M in an undisclosed round announced in Dec 2020.
4.3 years later, a Series D of $35.0M was announced in Mar 2025.
Vivace Therapeutics Founders and Leadership Team
Contact details for the Vivace Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Vivace Therapeutics Funding Compared to Other Biotechnology Startups
Vivace Therapeutics' latest round of $35.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vivace Therapeutics in Biotechnology and San Mateo
Companies Similar to Vivace Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Vivace Therapeutics Funding FAQs
What does Vivace Therapeutics do?
Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway. At Vivace Therapeutics, they pursue their work with passion, driven by a conviction to help people fight cancer and live life to the fullest. Based in the San Francisco Bay Area, Vivace Therapeutics is an oncology-focused portfolio-based drug discovery and development company adopting a capital-efficient and modality-indifferent approach to bring novel therapies to patients in need. Their experienced management team and world-class scientists work to advance promising drugs and therapeutic technologies that they believe can help conquer cancer.
How much funding has Vivace Therapeutics raised?
Vivace Therapeutics has raised $65.0M across 2 rounds on record. The most recent is a Series D of $35.0M announced in Mar 2025.
When did Vivace Therapeutics last raise funding?
Vivace Therapeutics' most recent funding round on record is a Series D of $35.0M, announced in Mar 2025.
Who founded Vivace Therapeutics?
FundedIQ lists Sofie Qiao (Founder) at Vivace Therapeutics.
Where is Vivace Therapeutics headquartered?
Vivace Therapeutics is based in San Mateo, California, United States.
How many employees does Vivace Therapeutics have?
Vivace Therapeutics is in the 11-50 employee band.
How does Vivace Therapeutics' funding compare to other Biotechnology startups?
Vivace Therapeutics' latest round of $35.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Vivace Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vivace Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.